Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions

Journal of Virology

Volumn 68, Issue 5, 1994, Pages 2803-2810

  Koelle, David M ^a,e   Corey, Lawrence ^a   Burke, Rae Lyn ^b   Eisenberg, Roselyn J ^c   Cohen, Gary H ^c   Pichyangkura, Rath ^d   Triezenberg, Steven J ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e Pacific Medical Centers   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; HLA DQ ANTIGEN; VIRUS ANTIGEN;

ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENITAL HERPES; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; PEPTIDE MAPPING; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0028301850     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.68.5.2803-2810.1994     Document Type: Article

References (56)

1. Ashley, R., C. Critchlow, M. Shurtleff, and L. Corey. 1988. Differential effect of systemic acyclovir treatment of genital HSV-2 infections on antibody responses to individual HSV-2 proteins. J. Med. Virol. 24:309-320.
2. Ashley, R. A., J. Militoni, F. Lee, A. Nahmias, and L. Corey. 1988. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunoblot for detecting antibodies to herpes simplex types 1 and 2 in human sera. J. Clin. Microbiol. 26:662-667.
3. Barker, D. E., and B. Roizman. 1990. Identification of three genes nonessential for growth in cell culture near the right terminus of the unique sequences of long component of herpes simplex virus type 1. Virology 177:684-691.
4. Barker, D. E., and B. Roizman. 1992. The unique sequence of the herpes simplex virus 1 L component contains an additional translated open reading frame designated UL49.5. Virology 66: 562-566.
5. Barnett, B. C., A. Dolan, E. A. R. Telford, A. J. Davison, and D. J. McGeoch. 1992. A novel herpes simplex virus gene (UL49A) encodes a putative membrane protein with counterparts in other herpesviruses. J. Gen. Virol. 73:2167-2171.
6. Batterson, W., and B. Roizman. 1983. Characterization of the herpes simplex virus-associated factor responsible for the induction of α genes. J. Virol. 46:371-377.
7. Brodsky, F. M., and L. E. Goagliardi. 1991. The cell biology and antigen processing and presentation. Annu. Rev. Immunol. 9:707-744.
8. Burke, R. L. 1991. Development of a herpes simplex virus subunit glycoprotein vaccine for prophylactic and therapeutic use. Rev. Infect. Dis. 13:S906-S911.
9. Chicz, R. M., R. G. Urban, J. C. Gorga, D. A. A. Vignali, W. S. Lane, and J. L. Strominger. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:27-47.
10. Conley, A. J., D. M. Knipe, P. C. Jones, and B. Roizman. 1981. Molecular genetics of herpes simplex virus. VII. Characterization of a temperature-sensitive mutant produced by in vitro mutagenesis and defective in DNA synthesis and accumulation of τ polypeptides. J. Virol. 37:191-206.
11. Cress, A., and S. J. Triezenberg. 1991. Nucleotide and deduced amino acid sequence of the gene encoding virion protein 16 of herpes simplex virus type 2. Gene 103:235-238.
12. Cunningham, A. L., and J. R. Noble. 1989. Role of keratinocytes in human recurrent herpetic lesions. J. Clin. Invest. 83:490-496.
13. Cunningham, A. L., R. R. Turner, A. C. Miller, M. F. Para, and T. C. Merigan. 1985. Evolution of recurrent herpes simplex lesions: an immunohistologic study. J. Clin. Invest. 75:226-233.
14. Dayan, C. M., M. Londei, A. E. Corcoran, et al. 1991. Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. Proc. Natl. Acad. Sci. USA 88:7415-7419.
15. Debroy, C. 1990. Nucleotide sequence of the herpes simplex type 2 syn gene that causes cell fusion. Gene 88:275-277.
16. Elliott, G. D., and D. M. Meredith. 1992. The herpes simplex virus type 1 tegument protein VP22 is encoded by gene UL49. J. Gen. Virol. 73:723-736.
17. Fleischer, B. 1984. Acquisition of specific cytotoxic activity by human T4+ lymphocytes in culture. Nature (London) 308:365-367.
18. Hendricks, R. L., T. M. Tumpey, and A. Finnegan. 1992. IFN-τ and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J. Immunol. 149:3023-3028.
19. Ho, M. 1990. Interferon as an agent against herpes simplex virus. J. Invest. Dermatol. 95:158S-160S.
20. Hudson, L., and F. C. Hay. 1989. Practical immunology, 3rd ed. Blackwell Scientific Publications, Oxford.
21. Kimura, S., T. Kotani, O. W. McBride, et al. 1987. Human thyroid peroxidase: complete cDNA and protein sequence, chromosome mapping, and identification of two alternatively spliced mRNAs. Proc. Natl. Acad. Sci. USA 84:5555-5559.
22. Kit, S., M. Kit, H. Qavi, D. Trkula, and H. Otsuka. 1983. Nucleotide sequence of the herpes simplex virus type 2 (HSV-2) thymidine kinase gene and predicted amino acid sequence of thymidine kinase polypeptide and its comparison with the HSV-1 thymidine kinase gene. Biochim. Biophys. Acta 741:158.
23. Koelle, D. M., H. Abbo, A. Peck, K. Ziegweid, and L. Corey. Direct recovery of HSV-specific T lymphocyte clones from human recurrent HSV-2 lesions. J. Infect. Dis., in press.
24. Leung, K. N., A. A. Nash, D. Y. Sia, and P. Wildy. 1984. Clonal analysis of T-cell responses to herpes simplex virus: isolation, characterization and antiviral properties of an antigen-specific helper T-cell clone. Immunology 53:623-633.
25. McGeoch, D. J., C. Cunningham, G. McIntyre, and A. Dolan. 1991. Comparative sequence analysis of the long repeat regions and adjoining parts of the long unique regions in the genomes of herpes simplex viruses types 1 and 2. J. Virol. 72:3057-3075.
26. McGeoch, D. J., M. A. Dalrymple, A. J. Davison, et al. 1988. The complete DNA sequence of the long unique region of herpes simplex virus type 1. J. Gen. Virol. 69:1531-1574.
27. Moretta, A., G. Pantaleo, L. Moretta, J.-C. Cerottini, and M. C. Mingari. 1983. Direct demonstration of the clonogenic potential of every human peripheral blood T cell. J. Exp. Med. 157:743-754.
28. Nash, A. A., A. Jayasuriya, J. Phelan, S. P. Cobbold, H. Waldman, and T. Prospero. 1987. Different roles for the L3T4+ and Lyt2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J. Gen. Virol. 68:825-833.
29. O'Hare, P. 1992. Targets for antiviral chemotherapy: herpes simplex virus regulatory protein, Vmw65. Antiviral Chem. Chemother. 2:1-7.
30. Olivo, P. D., N. J. Nelson, and M. D. Challberg. 1989. Herpes simplex virus type 1 gene products required for DNA replication: identification and overexpression. J. Virol. 63:196-204.
31. Para, M. F., K. M. Zezulak, A. J. Conley, M. Weinberger, K. Snitzer, and P. G. Spear. 1983. Use of monoclonal antibodies against two 75,000-molecular-weight glycoproteins specified by herpes simplex virus type 2 in glycoprotein identification and gene mapping. J. Virol. 45:1223-1227.
32. Purves, F. C., D. Spector, and B. Roizman. 1991. The herpes simplex virus type 1 protein kinase encoded by the US3 gene mediates posttranslational modification of the phosphoprotein encoded by the UL34 gene. J. Virol. 65:5757-5764.
33. Roizman, B., and A. E. Sears. 1990. Herpes simplex viruses and their replication. p. 1795-1841. In B. N. Fields and D. M. Knipe (ed.), Virology, 2nd ed. vol. 2. Raven Press, Ltd., New York.
34. Roizman, B., and M. Tognon. 1983. Restriction endonuclease patterns of herpes simplex virus DNA: application to diagnosis and molecular epidemiology. Curr. Top. Microbiol. Immunol. 104:274-286.
35. Royston, I., M. B. Omary, and I. S. Trowbridge. 1981. Monoclonal antibodies to a human T-cell antigen and Ia-like antigen in the characterization of lymphoid leukemia. Transplant. Proc. 13:761-766.
36. Sadowski, I., J. Ma, S. Triezenberg, and M. Ptashne. 1988. Gal4-VP16 is an unusually potent transcriptional activator. Nature (London) 335:563-564.
37. Schmidt, N. J. 1989. Cell culture procedures for diagnostic virology, p. 57-100. In N. J. Schmidt and R. W. Emmons (ed.), Diagnostic procedures for viral, rickettsial and chlamydial infections, 6th ed. American Public Health Association, Washington, D.C.
38. Shen, F., J. G. Reddy, R. Pichyangkura, and S. Triezenberg. Unpublished data.
39. Smith, L. M., H. R. Petty, P. Parham, and H. M. McConnell. 1982. Cell surface properties of HLA antigens in Epstein-Barr virus-transformed cell lines. Proc. Natl. Acad. Sci. USA 79:608-612.
40. Spits, H., J. Borst, M. Giphart, J. Cougan, C. Terhorst, and T. E. De Vries. 1984. HLA-DC antigens can serve as recognition elements for human cytotoxic T lymphocytes. Eur. J. Immunol. 14:299-304.
41. Spruance, S. L., and F. S. Chow. 1980. Pathogenesis of herpes simplex virus in cultures of epidermal cells from subjects with frequent recurrences. J. Infect. Dis. 142:671-675.
42. Swain, M. A., R. W. Peet, and D. A. Galloway. 1985. Characterization of the gene encoding herpes simplex virus type 2 glycoprotein C and comparison with the type 1 counterpart. J. Virol. 53:561-569.
43. + herpes simplex virus-specific cytotoxic T lymphocyte clones recognize diverse virion protein antigens. J. Virol. 66:1622-1634.
44. Torseth, J. W., G. H. Cohen, R. J. Eisenberg, P. W. Berman, L. A. Lasky, C. P. Cerini, C. J. Heilman, S. Kerwar, and T. C. Merigan. 1987. Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses. J. Virol. 61:1532-1539.
45. Watson, R. J. 1983. DNA sequence of the herpes simplex virus type 2 glycoprotein D gene. Gene 26:307-312.
46. Weinheimer, S. P., B. B. Boyd, S. K. Durham, J. L. Resnick, and D. R. O'Boyle. 1992. Deletion of the VP16 open reading frame of herpes simplex virus type 1. J. Virol. 66:258-269.
47. Whitley, R. J. 1990. Herpes simplex viruses, p. 1843-1887. In B. N. Fields and D. M. Knipe (ed.), Virology, 2nd ed. Raven Press, Ltd., New York.
48. Williams, M. V. 1988. Herpes simplex virus-induced dUTPase: target site for antiviral chemotherapy. Virology 166:262-264.
49. Yasukawa, M., A. Inatsuki, T. Horiuchi, and Y. Kobayashi. 1991. Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells. J. Immunol. 146:1341-1347.
50. Yasukawa, M., A. Inatsuki, and Y. Kobayashi. 1988. Helper activity in antigen-specific antibody production mediated by CD4+ human cytotoxic T cell clones directed against herpes simplex virus. J. Immunol. 140:3419-3425.
51. Yasukawa, M., and Y. Kobayashi. 1985. Inhibition of herpes simplex virus replication in vitro by human cytotoxic T cell clones and natural killer cell clones. J. Gen. Virol. 66:2225-2229.
52. Yasukawa, M., and J. M. Zarling. 1984. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA Class II MB and DR antigens. J. Immunol. 133:422-427.
53. Zarling, J. M., P. A. Moran, R. L. Burke, C. Pachl, P. W. Berman, and L. A. Lasky. 1986. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD-1. J. Immunol. 136:4669-4673.
54. Zezulak, K. M., and P. G. Spear. 1984. Mapping of the structural gene for the herpes simplex virus type 2 counterpart of herpes simplex virus type 1 glycoprotein C and identification of a type 2 mutant which does not express this glycoprotein. J. Virol. 49:741-747.
55. Zhang, Y., and J. L. C. McKnight. 1993. Herpes simplex virus type 1 UL46 and UL47 deletion mutants lack VP11 and VP12 or VP13 and VP14, respectively, and exhibit altered thymidine kinase expression. J. Virol. 67:1482-1492.
56. Zwaagstra, J. C., and W.-C. Leung. 1987. The nucleotide sequence of herpes simplex virus type 2 (333) glycoprotein gB2 and analysis of predicted antigenic sites. Can. J. Microbiol. 33:879-887.